Clinical Trial: CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-hodgkin Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase I Study of Bivalent CD79b and CD19 Directed CAR T Cells in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma
Brief Summary:
This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory Non-Hodgkin Lymphoma and to understand the side effects when treated with CD79b-19 CAR T cells.This research study involves the study drugs:CD79b-19 CAR T cellsFludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
Read more